Form Type: 4

SEC EDGAR Link
Accession Number:0001127602-21-019437
Date:2021-06-07
Issuer: CVS HEALTH CORP (CVS)
Original Submission Date:

Reporting Person:

FINKE DANIEL P
ONE CVS DRIVE
WOONSOCKET, RI 02895

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-07 M 32,320 a $54.19 60,904 direct
COMMON STOCK 2021-06-07 S 37,594 d $86.60 23,310 direct
COMMON STOCK (PEP) 2021-06-07 0 $0.00 3,042 direct
COMMON STOCK (RESTRICTED) 2021-06-07 0 $0.00 25,701 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION 54.19 2021-06-07 deemed execution date M 32,320 (d) 2020-04-01 2029-04-01 common stock 32,320 $54.19 32,322 direct
STOCK OPTION 58.34 2021-06-07 deemed execution date 0 ( ) 2021-04-01 2030-04-01 common stock 54,332 $58.34 54,332 direct
STOCK OPTION 74.3 2021-06-07 deemed execution date 0 ( ) 2022-04-01 2031-04-01 common stock 82,066 $74.30 82,066 direct
STOCK OPTION 52.37 2021-06-07 deemed execution date 0 ( ) 2022-05-31 2029-05-31 common stock 28,640 $52.37 28,640 direct
Footnotes
IDfootnote
f1 all sales were effected pursuant to a rule 10b5-1 plan.
f2 represents weighted average sale price for this group of sales, which occurred on the same trading day. multiple sales were executed, with sales prices ranging from $86.52 and $86.71 per share.
f3 option became exercisable in four equal annual installments, beginning on 4/1/2020.
f4 option became exercisable in four equal annual installments, commencing 4/1/2021.
f5 option becomes exercisable in four equal installments, commencing 4/1/2022.
f6 option becomes exercisable in three equal installments, commencing 5/31/2022.
WhaleWisdom Logo

Elevate your investments